13,683 Shares in ProAssurance Corporation (NYSE:PRA) Bought by XTX Topco Ltd

XTX Topco Ltd purchased a new position in ProAssurance Corporation (NYSE:PRA - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,683 shares of the insurance provider's stock, valued at approximately $319,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in PRA. JPMorgan Chase & Co. boosted its holdings in ProAssurance by 28.0% in the fourth quarter. JPMorgan Chase & Co. now owns 323,955 shares of the insurance provider's stock worth $5,154,000 after acquiring an additional 70,780 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in ProAssurance by 19.6% in the fourth quarter. Wells Fargo & Company MN now owns 40,164 shares of the insurance provider's stock worth $639,000 after acquiring an additional 6,583 shares in the last quarter. Envestnet Asset Management Inc. bought a new position in ProAssurance in the fourth quarter worth approximately $228,000. Scotia Capital Inc. bought a new position in ProAssurance in the fourth quarter worth approximately $173,000. Finally, Sterling Capital Management LLC boosted its holdings in ProAssurance by 859.4% in the fourth quarter. Sterling Capital Management LLC now owns 1,631 shares of the insurance provider's stock worth $26,000 after acquiring an additional 1,461 shares in the last quarter. Institutional investors own 85.58% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on PRA shares. Piper Sandler increased their price target on ProAssurance from $18.00 to $25.00 and gave the stock a "neutral" rating in a report on Thursday, May 8th. Wall Street Zen started coverage on ProAssurance in a report on Monday, May 19th. They issued a "hold" rating on the stock. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $21.50.

ProAssurance Stock Down 0.4%

Shares of PRA stock traded down $0.11 during trading hours on Friday, reaching $23.87. The company had a trading volume of 83,149 shares, compared to its average volume of 655,711. ProAssurance Corporation has a 12 month low of $12.43 and a 12 month high of $24.14. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.26 and a quick ratio of 0.26. The business has a fifty day simple moving average of $23.48 and a 200-day simple moving average of $21.21. The company has a market cap of $1.23 billion, a price-to-earnings ratio of 25.39 and a beta of 0.13.

ProAssurance (NYSE:PRA - Get Free Report) last posted its earnings results on Tuesday, August 5th. The insurance provider reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.33. ProAssurance had a return on equity of 5.62% and a net margin of 4.33%. The company had revenue of $271.94 million for the quarter, compared to analyst estimates of $266.72 million. During the same quarter last year, the company earned $0.23 earnings per share. The company's revenue for the quarter was down 19.9% on a year-over-year basis. On average, research analysts expect that ProAssurance Corporation will post 0.8 earnings per share for the current fiscal year.

ProAssurance Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.